Joseph G. Oberlander, Ph.D., PMP., CAPM
CMC & Project Management
Dr. Joseph Oberlander is an experienced pharmaceutical program and project manager with deep expertise in clinical supply chain strategy and operations. With a strong scientific foundation in neuronal cell biology, synaptic physiology, and pre-clinical models of CNS and endocrine diseases, Dr. Oberlander brings a unique blend of technical knowledge and operational acumen to drug development programs.
His background spans medical device evaluation, small-molecule and biologics development for CNS and oncology indications, and clinical trial support. Dr. Oberlander excels in scientific project management, pre-clinical study design, analytical method development, and statistical data analysis. He also has a strong command of computational tools, including machine learning and advanced data visualization, and continuously stay informed through active engagement with scientific literature.
A collaborative leader and mentor, Dr. Oberlander is known for solving complex technical challenges with creativity and strategic insight, while fostering team growth and effective cross-functional communication.
Joseph G. Oberlander, Ph.D., PMP., CAPM's Recent Articles
The Real Cost of Uncertainty: Why On-Again, Off-Again Tariffs Hurt Biotech Supply Chains
In drug development, and especially for smaller and medium-sized biotech companies, consistency is everything. From regulatory pathways to R&D timelines to global supply chains — predictability enables progress. But there’s one growing source of disruption that biotech leaders are increasingly…
Read Full Article
The U.S.-China Trade War and Its Impacts on Investigational Drug Supply Chains
The ongoing U.S.-China trade war, now entering its seventh year, has evolved beyond tariffs into a broader strategic contest over technology, industrial policy, and national security. For the pharmaceutical sector — particularly the supply chains evolved to manufacture investigational drugs…